STOCKHOLDERS' EQUITY (Details) |
1 Months Ended | |||
---|---|---|---|---|
Jul. 02, 2021
$ / shares
shares
|
Aug. 31, 2018
$ / shares
shares
|
Jun. 30, 2023
Vote
$ / shares
shares
|
Dec. 31, 2022
$ / shares
shares
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Common Stock, Shares Authorized | 150,000,000 | 150,000,000 | 150,000,000 | |
Common Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 | 10,000,000 | |
Preferred stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | |
Conversion of stock shares issued | 14,182,854 | |||
IPO | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Number of shares issued | 9,984,463 | |||
RA Capital Healthcare Fund, L.P | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Share price | $ / shares | $ 0.0012 | |||
Number of shares issued | 241,467 | |||
Number of votes for each share of common stock | Vote | 1 |
X | ||||||||||
- Definition Represents the information pertaining to number of votes for each share of common stock. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|